论文部分内容阅读
目的:探讨小儿哮喘的有效治疗方法。方法:随机性纳入2014年1月至2015年3月期间我院收治的73例哮喘患儿作为研究对象,并将73例患儿分成治疗组(37例)和对照组(36例),均对两组患儿实施常规对症治疗,在常规对症治疗的基础上予以对照组患儿沙丁胺醇治疗,在对照组患儿的基础上予以治疗组患儿布地奈德治疗。结果:治疗组患儿咳嗽、呼吸困难等临床症状的缓解时间较均较对照组患者早(P<0.05),临床治疗总有效率为94.6%,与对照组患儿的77.8%比较,差异具有统计学意义(P<0.05),两组患儿均未发生严重药物不良反应。结论:沙丁胺醇、布地奈德联合使用治疗小儿哮喘,疗效确切,药物不良反应少。
Objective: To explore the effective treatment of pediatric asthma. Methods: A total of 73 children with asthma were enrolled in our hospital from January 2014 to March 2015, and 73 children were divided into treatment group (37 cases) and control group (36 cases) On the basis of routine symptomatic treatment, the control group received salbutamol treatment, and the control group was treated with budesonide on the basis of the control group. Results: The relief time of clinical symptoms such as cough and dyspnea in treatment group was earlier than that in control group (P <0.05), and the total effective rate in clinical treatment was 94.6%. Compared with 77.8% in control group, the difference was Statistical significance (P <0.05), two groups of children did not occur serious adverse drug reactions. Conclusion: The combination of salbutamol and budesonide for the treatment of pediatric asthma has definite curative effect and few adverse drug reactions.